These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1604551

  • 21. Mesenteric and intraepithelial lymphocytes are insufficient to cause rejection but able to mediate lethal graft-versus-host disease in small bowel transplants.
    Xia W, Brandeis JM, Sayegh M, Kirkman RL.
    Transplant Proc; 1994 Jun; 26(3):1508-9. PubMed ID: 8030013
    [No Abstract] [Full Text] [Related]

  • 22. Natural killer activity is down-regulated following allogeneic small bowel transplantation.
    Tice DG.
    Transplant Proc; 1992 Jun; 24(3):1135-6. PubMed ID: 1604554
    [No Abstract] [Full Text] [Related]

  • 23. Impact of 15-deoxyspergualin on MHC class I and II antigen expression following small bowel transplantation in rats.
    Fändrich F, Waaga AM, Jacob S, Schröder J, Schweizer E, Schroeder P.
    Transplant Proc; 1994 Jun; 26(3):1592-3. PubMed ID: 8030051
    [No Abstract] [Full Text] [Related]

  • 24. Importance of lymphoid tissue for survival of small bowel allografts.
    Pirenne J, Williams JG, Kim S, Fryer J, Benedetti E, Hakim NS, Médot M, Najarian JS, Gruessner RW, Dunn DL.
    Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
    [No Abstract] [Full Text] [Related]

  • 25. Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: effect of depletion of T-cell subsets.
    Shaffer D, Simpson MA, Milford EL, Gottschalk R, Kut JP, Maki T, Monaco AP.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):679-81. PubMed ID: 1990646
    [No Abstract] [Full Text] [Related]

  • 26. Donor pretreatment with anti-T-cell receptor monoclonal antibodies prevents graft-vs-host disease in brequinar-treated small bowel allograft recipients.
    Wang M, Stepkowski SM, Kahan BD.
    Transplant Proc; 1995 Feb; 27(1):383. PubMed ID: 7879029
    [No Abstract] [Full Text] [Related]

  • 27. The role of passenger leukocytes in the immunogenicity of intestinal and cardiac allografts in the rat.
    Gundlach M, Oluwole S, D'Agati V, Chabot J, Broelsch CE, Hardy MA.
    Transplant Proc; 1992 Jun; 24(3):1131-2. PubMed ID: 1604552
    [No Abstract] [Full Text] [Related]

  • 28. Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model.
    Fändrich F, Exner B, Papachrysanthou A, Jahnke T, Chambers WH, Zavazava N.
    Transplant Proc; 1996 Oct; 28(5):2465-6. PubMed ID: 8907904
    [No Abstract] [Full Text] [Related]

  • 29. Changes in small intestinal microflora following small bowel transplantation in the rat and bacterial translocation in rejection and graft-versus-host disease.
    Price BA, Cumberland NS, Ingham Clark CL, Malcolm P, Crane PW, Lear PA, Wood RF.
    Transplant Proc; 1992 Jun; 24(3):1194. PubMed ID: 1604583
    [No Abstract] [Full Text] [Related]

  • 30. The effect of ultraviolet B-irradiated leukocyte transfusions in intestinal transplantation.
    Xiao F, Foster PF, Sankary HN, Kociss K, Templeton AC, Williams JW.
    Transplant Proc; 1992 Jun; 24(3):1167-8. PubMed ID: 1604572
    [No Abstract] [Full Text] [Related]

  • 31. Immunologic basis of small intestinal allograft rejection.
    Kim PC, Levy GA, Koh I, Cohen Z.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):830-2. PubMed ID: 1990704
    [No Abstract] [Full Text] [Related]

  • 32. Irradiation of the donor combined with cyclosporine A treatment of the recipient prevents graft-versus-host disease and leads to prolonged survival of small-bowel allografts.
    Saat RE, de Bruin RW, Heineman E, Jeekel J, Marquet RL.
    Transplant Proc; 1990 Dec; 22(6):2465-6. PubMed ID: 2264111
    [No Abstract] [Full Text] [Related]

  • 33. Modulation of graft-vs-host-related disease by host-specific natural killer cell activity following semiallogeneic small bowel transplantation in the rat.
    Fändrich F, Schröder J, Jahnke T, Dresske B, Chambers WH, Zavazava N.
    Transplant Proc; 1996 Dec; 28(6):3267-8. PubMed ID: 8962268
    [No Abstract] [Full Text] [Related]

  • 34. NK activity during graft-versus-host disease and graft rejection in rats following intestinal semiallogenic and allogenic transplantation with or without mesenteric lymphadenectomy.
    Frezza EE, Gerunda GE, Fassina A, DeFranchis R, Biffi R, Gurakar A, Fagiuoli S, Faccioli AM, Van Thiel DH.
    Transplantation; 1994 Sep 27; 58(6):698-701. PubMed ID: 7940689
    [Abstract] [Full Text] [Related]

  • 35. [Distribution of immunocompetent cells small intestine transplantation in rats].
    Hell K, Hansmann ML, Gundlach M, Schroeder P, Deltz E.
    Verh Dtsch Ges Pathol; 1991 Sep 27; 75():145-8. PubMed ID: 1724818
    [Abstract] [Full Text] [Related]

  • 36. Lymphocyte immunologic interactions in intestinal transplantation.
    Teitelbaum DH, Narasimhan A, Chenault RH, Merion RM.
    Transplant Proc; 1994 Jun 27; 26(3):1525-6. PubMed ID: 8030021
    [No Abstract] [Full Text] [Related]

  • 37. Graft-versus-host and host-versus-graft reactions after small intestine allografts in hyperimmunized rats: effect of cyclosporine treatment.
    Marni A, Ferrero ME, Tiengo M, Gaja G.
    Transplant Proc; 1987 Feb 27; 19(1 Pt 2):1207-11. PubMed ID: 3547856
    [No Abstract] [Full Text] [Related]

  • 38. The effects of various routes of administration of monoclonal anti-T cell antibodies for prevention of the graft-versus-host reaction following small bowel transplantation.
    Johnsson C, Tufveson G.
    Transplantation; 1994 Jan 27; 57(2):289-92. PubMed ID: 8310522
    [No Abstract] [Full Text] [Related]

  • 39. Antirejection strategy in small bowel transplantation.
    Wood RF.
    Transplant Proc; 1996 Oct 27; 28(5):2491-3. PubMed ID: 8907918
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.